CJC-1295 No DAC & Ipamorelin (Blend)

CJC-1295 & Ipamorelin is a precision-blended research combination containing both a modified GHRH 1-29 analogue and a selective GHSR agonist, currently being studied for their complementary interactions across growth hormone receptor signaling pathways in controlled laboratory settings. This compound is supplied exclusively for scientific research and is not approved for human or animal consumption.

CJC-1295 (No DAC) & Ipamorelin is a precision-blended research combination containing two complementary growth hormone pathway compounds: CJC-1295 (No DAC), a stabilized GHRH 1-29 analogue that interacts with GHRH receptors on pituitary somatotroph cells, and Ipamorelin, a selective pentapeptide GHSR agonist that interacts with ghrelin receptors through a mechanistically distinct pathway. Together, these compounds represent a dual-mechanism research system targeting two separate but complementary upstream growth hormone signaling pathways.

Current research investigates the CJC-1295 & Ipamorelin combination across a range of biological systems, including pituitary cell models, dual receptor pathway studies, growth hormone pulse research, and comparative mono versus combination peptide signaling investigations. Both compounds have been extensively studied individually, and the combination has become a frequently investigated pairing in growth hormone receptor pathway research due to its targeting of complementary receptor systems.

21 Peptide™ supplies CJC-1295 & Ipamorelin exclusively for scientific research purposes. This compound is not approved for human or animal consumption and is not intended for diagnostic, therapeutic, or clinical use.

‍

Chemical Specifications

‍

Component 1: CJC-1295 (No DAC)

‍CAS NO: 863288-34-0

‍Molecular Formula: C₁₅₂H₂₅₂N₄₄O₄₂

‍Molecular Weight: 3367.9 g/mol

‍

Component 2: Ipamorelin

‍CAS NO: 170851-70-4

‍Molecular Formula: C₃₈H₄₉N₁₀O

‍Molecular Weight: 711.9 g/mol

‍

Appearance: White powder 

Storage: 2-8°C

Quality Control

‍

Lot Number: 21P-CJCIPA-2602-BLU

Purity: 99.955%

Verified Peptide Content: Ipamorelin: 4.07 mg / CJC-1295: 5.42 mg

Testing Method: HPLC with UV Detection + LCMS/MS

‍

Testing Laboratory: Freedom Diagnostics

> Search Code: 21Pe2602230198

Analytical Verification

‍

Identity Confirmation: Mass spectrometry confirms the molecular structure of CJC-1295 (No DAC) and Ipamorelin.

Chromatographic Analysis: HPLC chromatogram verifies peptide purity and separation profile.

Testing Method:

- High-Performance Liquid Chromatography (HPLC)

- Mass Spectrometry (LCMS/MS)

Laboratory:

- Freedom Diagnostics - USA

- Principal Chemist: Stephen Schmidt